Package 69117-0019-1

{"route": ["ORAL"], "spl_id": "4727ec9e-f954-a44e-e063-6394a90a2c04", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0369117003916", "0369117003923"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["67e7b340-0635-2595-e053-2a91aa0ad266"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["YILING PHARMACEUTICAL, INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (69117-0019-1)", "package_ndc": "69117-0019-1", "marketing_start_date": "20180504"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (69117-0019-2)", "package_ndc": "69117-0019-2", "marketing_start_date": "20180504"}], "brand_name": "Acyclovir", "product_id": "69117-0019_4727ec9e-f954-a44e-e063-6394a90a2c04", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "69117-0019", "generic_name": "Acyclovir", "labeler_name": "YILING PHARMACEUTICAL, INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA210401", "marketing_category": "ANDA", "marketing_start_date": "20180504", "listing_expiration_date": "20261231"}